MARKET

NNVC

NNVC

NANOVIRICIDES
AMEX

Real-time Quotes | Nasdaq Last Sale

7.79
-0.92
-10.56%
Pre Market: 7.60 -0.19 -2.44% 08:42 07/10 EDT
OPEN
7.96
PREV CLOSE
8.71
HIGH
8.23
LOW
7.61
VOLUME
1.81M
TURNOVER
--
52 WEEK HIGH
19.20
52 WEEK LOW
1.271
MARKET CAP
70.68M
P/E (TTM)
-2.8608
1D
5D
1M
3M
1Y
5Y

Analyst Price Target

The average NNVC stock price target is 0.6000 with a high estimate of 0.6000 and a low estimate of 0.6000.

EPS

NNVC News

More
Mid-Afternoon Market Update: Dow Falls Over 300 Points; Veritone Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 1.2% to 25,754.70 while the NASDAQ rose 0.39% to 10,532.55. The S&P also fell, dropping 0.55% to 3,152.65.
Benzinga · 18h ago
Mid-Day Market Update: NASDAQ Turns Negative; Bed Bath & Beyond Shares Plunge
Midway through trading Thursday, the Dow traded down 1.89% to 25573.70 while the NASDAQ fell 0.79% to 10,409.73. The S&P also fell, dropping 1.50% to 3,122.45.
Benzinga · 20h ago
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)
Benzinga · 1d ago
NanoViricides Prices ~1.37M Share Offering At $7.30/Share
Benzinga · 1d ago
Covid-19 Research Update: The Stars and the Question Marks
GuruFocus.com · 1d ago
Why NanoViricides Stock Is Trading Higher Today
NanoViricides (NYSE: NNVC) shares are trading higher after the company announced the drug candidates it's developing against the coronavirus demonstrated safety and tolerability in an animal model.
Benzinga · 1d ago
Mid-Morning Market Update: Markets Open Higher; MSC Industrial Beats Q3 Estimates
Following the market opening Wednesday, the Dow traded up 0.80% to 26096.78 while the NASDAQ rose 1.26% to 10,474.14. The S&P also rose, gaining 0.78% to 3,169.98.
Benzinga · 1d ago
BIIB, MFGP among premarket gainers
Seeking Alpha - Article · 2d ago

Industry

Biotechnology & Medical Research
-0.44%
Pharmaceuticals & Medical Research
-0.78%

Hot Stocks

Symbol
Price
%Change

About NNVC

NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.
More

Webull offers kinds of NanoViricides Inc stock information, including AMEX:NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.